Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States

OBJECTIVE: To evaluate the accuracy of a 2015 cross-sectional analysis published in the BMJ Open which reported that pharmaceutical industry compliance with clinical trial registration and results reporting requirements under US law was suboptimal and varied widely among companies. DESIGN: We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassman, Scott M, Shopshear, Olivia M, Jazic, Ina, Ulrich, Jocelyn, Francer, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623439/
https://www.ncbi.nlm.nih.gov/pubmed/28942418
http://dx.doi.org/10.1136/bmjopen-2016-015110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623439/
https://www.ncbi.nlm.nih.gov/pubmed/28942418
http://dx.doi.org/10.1136/bmjopen-2016-015110

Ejemplares similares